|
Published by: Freedonia Group Inc
Published: Jun. 1, 2008 - 354 Pages
Table of Contents
- INTRODUCTION
- I. EXECUTIVE SUMMARY
- II. MARKET ENVIRONMENT
- General
- Demographic Trends
- Macroeconomic Outlook
- Consumer Spending
- Manufacturing Trends
- Food & Beverage Industry Outlook
- Agricultural Outlook
- Crop Production
- Livestock & Poultry
- National Health Expenditures
- Petroleum & Refining Industry Overview
- Historical Market Trends
- Pricing & Product Mix
- Environmental & Regulatory Considerations
- Intellectual Property Considerations
- International Activity
- Foreign Trade & US Production
- Exports
- Imports
- III. TECHNOLOGY
- General
- Enzyme Production Overview
- Recombinant DNA Technology
- Directed Evolution & Gene Shuffling
- Protein Engineering Technology
- Molecular Screening & Bioinformatics
- Enzyme Immobilization
- Extremeophilic Enzymes
- Enzyme Factories
- IV. MARKETS
- General
- Pharmaceuticals
- Pharmaceutical Industry Overview
- Enzyme Demand
- Enzyme Replacement Therapy
- Neuromodulator
- Digestive
- Cardiovascular Thrombolytic
- Other Pharmaceutical
- Starch Processing
- Ethanol
- Industry Outlook
- Enzyme Demand
- Sweeteners
- Industry Outlook
- Enzyme Demand
- Research & Biotechnology
- Research & Biotechnology Industry Outlook
- Enzyme Demand
- DNA Amplification & Sequencing
- Other Research Enzyme Markets
- Food & Beverage Processing
- Dairy Products
- Industry Outlook
- Enzyme Demand
- Bakery Products
- Industry Outlook
- Enzyme Demand
- Beverage Processing
- Industry Outlook
- Enzyme Demand
- Other Food & Beverage Applications
- Cleaning Products
- Cleaning Product Industry Outlook
- Enzyme Demand
- Laundry Detergents
- Dishwashing Detergents & Other Cleaners
- Diagnostics
- Diagnostic Industry Outlook
- Enzyme Demand
- Animal Feed
- Animal Feed Industry Outlook
- Enzyme Demand
- Other Enzyme Markets
- Biocatalysts
- Cosmetics & Toiletries
- Textile & Leather
- Pulp & Paper
- All Other
- V. PRODUCTS
- General
- Carbohydrases
- Alpha Amylases
- Glucoamylases
- Recombinant Human Glycosidases
- Cellulases
- Glucose Isomerases
- Lactases
- Pectinases
- Other Carbohydrases
- Proteases
- Microbial Proteases
- Fibrinolytic Proteases
- Rennet/Chymosin
- Other Proteases
- Polymerases
- Nucleases
- DNases
- Other Nucleases
- Lipases
- Other Enzymes
- VI. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Research & Development
- Cooperative Agreements
- Acquisitions & Divestitures
- Manufacturing
- Marketing & Distribution
- Company Profiles
- AB Enzymes, see Associated British Foods
- Advanced Enzyme Technologies Limited
- Agilent Technologies Incorporated
- Allergan Incorporated
- Amano Enzyme Incorporated
- Applera Corporation
- Applied Biosystems, see Applera Corporation
- Associated British Foods plc
- Axcan Pharma Incorporated
- BASF SE
- Biomethodes
- Biozyme Laboratories, see Inverness Medical Innovations
- Cargill Incorporated
- Chr. Hansen A/S
- Codexis Incorporated
- CSL Limited
- Danisco A/S
- DFB Pharmaceuticals Incorporated
- Dyadic International Incorporated
- EKR Therapeutics Incorporated
- Frutarom Limited
- Genentech Incorporated
- Genzyme Corporation
- Healthpoint, see DFB Pharmaceuticals
- ImaRx Therapeutics Incorporated
- Inverness Medical Innovations Incorporated
- Invitrogen Corporation
- Iogen Corporation
- Ipsen
- Johnson & Johnson
- Lonza Group Limited
- MP Biomedicals LLC
- National Enzyme Company
- New England BioLabs Incorporated
- Novozymes A/S
- Promega Corporation
- Roche Holding Limited
- Royal DSM NV
- Shire plc
- Solstice Neurosciences Incorporated
- Solvay SA
- Specialty Enzymes and Biochemicals, see
- Advanced Enzyme Technologies
- Stratagene, see Agilent Technologies
- Valley Research Incorporated
- Verenium Corporation
- Other Companies Mentioned in Study
- LIST OF TABLES
- SECTION I -- EXECUTIVE SUMMARY
- Summary Table
- SECTION II -- MARKET ENVIRONMENT
- 1 Population & Households
- 2 Macroeconomic Indicators
- 3 Personal Consumption Expenditures
- 4 Manufacturers’ Shipments
- 5 Food & Beverage Shipments
- 6 Agricultural Indicators
- 7 Major Crop Production
- 8 Livestock & Poultry Population
- 9 National Health Expenditures
- 10 Petroleum Industry Indicators
- 11 US Enzyme Market, 1997 - 2007
- 12 Selected Enzyme Pricing
- 13 Enzyme Production & Foreign Trade
- SECTION IV -- MARKETS
- 1 Enzyme Demand by Market
- 2 Pharmaceutical Shipments
- 3 Pharmaceutical Enzyme Demand by Market, Status & Product
- 4 Enzyme Replacement Therapy Enzyme Demand
- 5 Neuromodulator Enzyme Demand
- 6 Digestive Enzyme Demand by Application & Product
- 7 Cardiovascular Thrombolytic Enzyme Demand by Application, Type & Product
- 8 Other Pharmaceutical Enzyme Demand by Type & Product
- 9 Starch Processing Enzyme Demand
- 10 Ethanol Industry Indicators
- 11 Ethanol Production Enzyme Demand
- 12 Corn Sweetener Supply & Demand
- 13 Corn Sweetener Enzyme Demand by Application & Product
- 14 Research Expenditures
- 15 Research & Biotechnology Enzyme Demand by Market & Product
- 16 DNA Amplification & Sequencing Enzyme Demand
- 17 Other Research & Biotechnology Enzyme Demand
- 18 Food & Beverage Enzyme Demand by Application & Product
- 19 Dairy Product Shipments
- 20 Dairy Enzyme Demand by Application & Product
- 21 Cheese Production Enzyme Demand
- 22 Other Dairy Product Enzyme Demand
- 23 Bakery Product Shipments
- 24 Bakery Product Enzyme Demand
- 25 Beverage Shipments
- 26 Beverage Enzyme Demand
- 27 Other Food Processing Enzyme Demand
- 28 Cleaning Product Shipments
- 29 Cleaning Product Enzyme Demand
- 30 Laundry Detergent Enzyme Demand
- 31 Dishwashing & Other Cleaning Product Enzyme Demand
- 32 In Vitro Diagnostic Product Shipments
- 33 Diagnostic Enzyme Demand
- 34 Animal Feed Shipments
- 35 Animal Feed Enzyme Demand
- 36 Other Markets Demand for Enzymes
- 37 Biocatalyst Enzyme Demand
- 38 Cosmetic & Toiletry Enzyme Demand
- 39 Textile & Leather Enzyme Demand
- 40 Pulp & Paper Enzyme Demand
- 41 All Other Markets for Enzymes
- SECTION V -- PRODUCTS
- 1 Enzyme Demand by Product
- 2 Carbohydrase Demand by Product & Market
- 3 Alpha Amylase Demand
- 4 Glucoamylase Demand
- 5 Recombinant Human Glycosidase Demand
- 6 Cellulase Demand
- 7 Glucose Isomerase Demand
- 8 Lactase Demand
- 9 Pectinase Demand
- 10 Other Carbohydrase Demand
- 11 Protease Demand by Product & Market
- 12 Microbial Protease Demand
- 13 Fibrinolytic Protease Demand
- 14 Rennet/Chymosin Demand
- 15 Other Protease Demand
- 16 Polymerase Demand
- 17 Nuclease Demand by Product & Market
- 18 DNase Demand
- 19 Other Nuclease Demand
- 20 Lipase Demand
- 21 Other Enzyme Demand
- SECTION VI -- INDUSTRY STRUCTURE
- 1 Enzyme Sales by Company, 2007
- 2 Selected Cooperative Agreements
- 3 Selected Acquisitions & Divestitures
- LIST OF CHARTS
- SECTION II -- MARKET ENVIRONMENT
- 1 Enzyme Market, 1997 - 2007
- 2 Enzyme Exports by Country, 2007
- 3 Enzyme Imports by Country, 2007
- SECTION IV -- MARKETS
- 1 Enzyme Demand by Market, 2007
- SECTION V -- PRODUCTS
- 1 Enzyme Demand by Product, 2007
- SECTION VI -- INDUSTRY STRUCTURE
- 1 Enzyme Market Share, 2007
AbstractUS demand to grow 6% annually through 2012
US demand for enzymes will rise nearly six percent per year to $2.5 billion in 2012. Advances will be led by continued rapid expansion in the fuel ethanol enzyme market, as well as strong growth in the large pharmaceutical and smaller biocatalyst and pulp and paper markets. Healthy gains will also be realized in diagnostics, research and biotechnology, and cosmetics and toiletries, although this will be offset somewhat by maturity in food and beverages, animal feed and cleaning products applications.
Growth in the US enzyme industry will be dominated by the rapid expansion of the fuel ethanol industry, as ethanol producers strive to meet the country’s renewable fuel needs specified in the Energy Independence and Security Act of 2007. Even as the country reaches a practical limit on how much corn it can convert into ethanol, the rise of second generation, cellulosic biomass ethanol production will continue to drive rapid enzyme demand growth over the longer term.
Pharmaceuticals will remain dominant market
Pharmaceuticals, which will remain the largest enzyme market going forward, will also achieve above average growth. Advances will stem from continuing strong demand for neuromodulators and orphan drug enzymes for treating lysosomal storage disorders. Fast expansion in smaller pharmaceutical applications such as cancer treatment and wound debridement will also support gains.Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|